RIM
MRNA icon

Rakuten Investment Management’s Moderna MRNA Stock Holding History

Rakuten Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
37,441
+3,192
+9% +$165K 0.01% 381
2026
Q1 		$1.65M Buy
34,249
+3,238
+10% +$151K ﹤0.01% 395
2025
Q4 		$966K Buy
31,011
+27,027
+678% +$734K ﹤0.01% 509
2025
Q3 		$9.97M Buy
+3,984
New +$111K 0.04% 135
2025
Q1 		$953K Buy
+30,633
New +$1.09M ﹤0.01% 502
2024
Q3 		$1.82M Buy
27,681
+7,301
+36% +$670K 0.01% 254
2024
Q2 		$2.47M Buy
20,380
+7,862
+63% +$995K 0.02% 151
2024
Q1 		$1.33M Buy
12,518
+11,704
+1,438% +$1.18M 0.01% 171
2023
Q4 		$80.4K Buy
+814
New +$68.5K ﹤0.01% 227

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Rakuten Investment Management's MRNA Position: Q2 2026 in Review

Rakuten Investment Management increased its Moderna (MRNA) stake by 9.3% in Q2 2026, buying an estimated $165K and bringing the position to 37,441 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #381.

Rakuten Investment Management first reported a position in MRNA in Q4 2023 and has held it in 9 quarters since. The position peaked at $9.97M in Q3 2025. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Rakuten Investment Management held 37,441 shares of Moderna worth $2.61M as of Q2 2026.
  • Rakuten Investment Management bought 3,192 Moderna shares in Q2 2026, an estimated $165K.
  • Moderna made up 0.01% of Rakuten Investment Management's portfolio in Q2 2026, its #381 holding.
  • Rakuten Investment Management first reported a position in Moderna in Q4 2023 and has held it in 9 quarters since.
  • Rakuten Investment Management's Moderna position peaked at $9.97M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.